Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodeghiero

Showing results (11-20 of 266) with videos related to

Pageof 27
Sort By:
British Journal of Haematology|June 1, 1996
Pregnancy in women with essential thrombocythaemiaM Frezzato, F Rodeghiero
Oncology|October 31, 2003
Ifosfamide in hematological malignancies of adultsF Rodeghiero, F Elice
Thrombosis Research|February 15, 1995
Platelet ristocetin cofactor (RiCof) in patients with type I "platelet normal" von Willebrand disease correlates with plasma RiCof peak after desmopressin infusionG Castaman, F Rodeghiero
Thrombosis and Haemostasis|July 1, 1997
The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis ProjectF Rodeghiero, A Tosetto
Clinical and Laboratory Haematology|January 1, 1991
Parallel line bioassay in a coagulation laboratory. A program for personal computer use and an example application to Ristocetin Cofactor assayA Tosetto, F Rodeghiero
Leukemia|January 1, 1994
The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemiaF Rodeghiero, G Castaman
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Desmopressin and type II B von Willebrand diseaseG Castaman, F Rodeghiero
Haematologica|November 1, 1993
Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 casesC Schiavotto, F Rodeghiero
Thrombosis and Haemostasis|December 18, 1987
Calibration of lyophilized standards for ristocetin cofactor activity of von Willebrand Factor (vWF) requires vWF-deficient plasma as diluent for dose-response curvesF Rodeghiero, G Castaman
Annals of Internal Medicine|April 24, 1999
Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolismF Rodeghiero, A Tosetto
Pageof 27

Showing results (11-20 of 266) with videos related to

Sort By:
Pageof 27
British Journal of Haematology|June 1, 1996
Pregnancy in women with essential thrombocythaemiaM Frezzato, F Rodeghiero
Oncology|October 31, 2003
Ifosfamide in hematological malignancies of adultsF Rodeghiero, F Elice
Thrombosis Research|February 15, 1995
Platelet ristocetin cofactor (RiCof) in patients with type I "platelet normal" von Willebrand disease correlates with plasma RiCof peak after desmopressin infusionG Castaman, F Rodeghiero
Thrombosis and Haemostasis|July 1, 1997
The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis ProjectF Rodeghiero, A Tosetto
Clinical and Laboratory Haematology|January 1, 1991
Parallel line bioassay in a coagulation laboratory. A program for personal computer use and an example application to Ristocetin Cofactor assayA Tosetto, F Rodeghiero
Leukemia|January 1, 1994
The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemiaF Rodeghiero, G Castaman
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Desmopressin and type II B von Willebrand diseaseG Castaman, F Rodeghiero
Haematologica|November 1, 1993
Twenty years experience with treatment of idiopathic thrombocytopenic purpura in a single department: results in 490 casesC Schiavotto, F Rodeghiero
Thrombosis and Haemostasis|December 18, 1987
Calibration of lyophilized standards for ristocetin cofactor activity of von Willebrand Factor (vWF) requires vWF-deficient plasma as diluent for dose-response curvesF Rodeghiero, G Castaman
Annals of Internal Medicine|April 24, 1999
Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolismF Rodeghiero, A Tosetto
Pageof 27